Nasdaq4d
Polyrizon Ltd. Initiates Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdoses
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...
Polyrizon Ltd.: Polyrizon Signs Non- Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
Polyrizon Ltd.: Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...
Global News1d
Saskatchewan provincial government responds to drug crisis in Saskatoon
The alert states that four to five doses of naloxone were required to revive patients, adding oxygen and paramedic response have also been needed. Prairie Harm reduction reports it has responded ...
Seeking Alpha5d
Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025
Buprenorphine and Naloxone are 2.7%. Buprenorphine is an active ingredient in Belbuca. The company has avoided larger lawsuit settlements as the company’s focus is on non-abusive design of the ...
Medscape1d
Drug Incompatibility Chemistry
Most organic drugs contain one acid group, usually a carboxylic acid, -COOH, or one basic primary, secondary, or tertiary amino group, NC 1-3, [3,22,27,28,29] that determines the acid-base ...